Send to a Friend Font Size: Increase Decrease

ARGX and 1ZLB Related Headlines

Aug 17, 2026 06:00AM Zai Lab and argenx report Phase 3 trial win for myositis drug
Aug 17, 2026 06:00AM Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

ARGX and 1ZLB Related Press Releases

Aug 17, 2026 06:00AM Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

ARGX and 1ZLB Related SEC Filings